- Status:
- Do Not Prescribe (DNP), Red
- Decision Date:
- November 2021
Comments
RED: Treatment of influenza and post-exposure prophylaxis of influenza in adults and children aged 12 and over (Decision date February 2026)
DO NOT PRESCRIBE (DNP)
- NICE TA1135: (terminated appraisal) Baloxavir marboxil for treating and preventing influenza in children 1 to 11 years (Decision date March 2026)
Do Not Prescribe (DNP) Drug Classifications
- 6: Have NICE guidance that recommends they should not be used
Red Drug Classifications
- 1: Requiring specialist assessment to enable patient selection, initiation and ongoing treating
search again
